| Literature DB >> 25960791 |
Nai Liang Li1, Wen-Ling Peng1, Chia-Chuan Liu2, Chih-Hsun Shih2.
Abstract
INTRODUCTION: The conventional approach during thoracoscopic esophagectomy was performed in the left lateral decubitus position (LLDP). Recently, thoracoscopic esophagectomy in the prone position (PP) has attracted the attention of surgeons. AIM: To report institutional experience with thoracoscopic esophagectomy in PP and compare it with the conventional LLDP approach.Entities:
Keywords: esophageal cancer; minimally invasive esophagectomy; prone position; thoracoscopic esophagectomy
Year: 2015 PMID: 25960791 PMCID: PMC4414103 DOI: 10.5114/wiitm.2015.48698
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Baseline characteristics (n = 59)
| Parameter | LLDP ( | PP ( | Value of |
|---|---|---|---|
| Age, mean ± SD [years] | 56.1 ±9.6 | 55.6 ±9.4 | 0.83 |
| Gender, male/female, | 35/3 | 19/2 | 1.00 |
| BW, mean ± SD [kg] | 61.8 ±8.9 | 65.2 ±11.3 | 0.21 |
| BH, mean ± SD [cm] | 166.4 ±6.8 | 168.2 ±7.2 | 0.34 |
| ASA (II/III/IV), | 17/20/1 | 7/14/0 | 0.21 |
| Nonsmoking or quit > 3 months, | 19 (50) | 11 (52.4) | 0.86 |
| Clinical stage (AJCC 6th edition) I/II/III/IV/V, | 8/7/19/1/3 | 2/17/12/0/0 | 0.38 |
| Preop CCRT (yes/no), | 25/13 | 14/7 | 0.95 |
| Cell type (SCC/Ad-ca), | 36/2 | 21/0 | 0.53 |
| Location, u/m/l, | 8/17/13 | 2/14/5 | 0.25 |
| Preoperative PFT: | |||
| FVC | 101.2 ±16.9 | 101.8 ±14.7 | 0.88 |
| FEV1 | 93.6 ±15.8 | 95.5 ±13.9 | 0.65 |
| DLCO | 95.8 ±20.7 | 91.6 ±19.7 | 0.45 |
| Preoperative conditions/comorbidities: | |||
| Anemia, | 26 (68.4) | 13 (61.9) | 0.61 |
| DM, | 5 (13.2) | 1 (4.8) | 0.41 |
| Cirrhosis, | 3 (7.9) | 2 (9.5) | 0.75 |
| Hb mean ± SD [g/dl] | 12.7 ±1.6 | 12.7 ±1.9 | 0.94 |
| Albumin, mean ± SD [mg%] | 4.2 ±0.3 | 4.2 ±0.3 | 0.99 |
| Pain control modality: | 0.45 | ||
| EI/contPVB, | 37 (97.4) | 21 (100) | |
| PCA, | 1 (2.6) | 0 (0) |
BW – body weight, BH – body height, ASA – American Society of Anesthesiologists classification, Preop CCRT – preoperative chemoradiotherapy, SCC – squamous cell carcinoma, Ad-ca – adenocarcinoma, u/m/l – upper/middle/lower, preoperative PFT – preoperative pulmonary function test, EI/contPVB – epidural infusion or continuous paravertebral block, PCA – patient-controlled analgesia, AJCC – American Joint Committee on Cancer, FVC – forced vital capacity, FEV1 – forced expiratory volume in the first second, DLCO – diffusing capacity of the lungs for carbon monoxide, DM – diabetes mellitus, Hb – hemoglobin.
Operative parameters
| Parameter | LLDP ( | PP ( | Value of |
|---|---|---|---|
| Mean airway pressure, mean ± SD [cm H2O] | 24.1 ±3.7 | 23.9 ±3.1 | 0.88 |
| Intraop desaturation, yes/no, | 1/37 | 0/21 | 1.00 |
| Low TV, | 18 (47.4) | 16 (76.2) | 0.03 |
| Estimated blood loss, mean ± SD [ml] | 104.9 ±93.3 | 120.6 ±102.4 | 0.55 |
| Blood transfusion, | 6 (15.8) | 5 (23.8) | 0.50 |
| Volume of colloid and PRBC, mean ± SD [ml] | 784.2 ±458.3 | 595.2 ±464.2 | 0.14 |
| Conversion to open thoracotomy, | 0 (0) | 0 (0) | 1.00 |
| NO of LN dissected in thorax, mean ± SD | 29.9 ±12.7 | 27.2 ±11.9 | 0.42 |
| Thoracic operative time, mean ± SD [h] | 3.9 ±0.7 | 3.4 ±0.7 | 0.03 |
| Total operative duration, mean ± SD [h] | 6.8 ±1 | 7.0 ±1.1 | 0.50 |
| Ventilator dependence, mean ± SD [days] | 0.2 ±1.0 | 0.0 ±0.0 | 0.46 |
| ICU stay, mean ± SD [days] | 1.5 ±1.4 | 1.0 ±0 | 0.03 |
| Hospital stay, mean ± SD [days] | 14.2 ±5.8 | 12.6 ±3.2 | 0.17 |
| NRS pain score, median (Q1, Q3): | |||
| POD 0 | 5 (3, 8) | 3 (0, 6) | 0.10 |
| POD 1 | 4.5 (3, 6) | 4 (2, 8) | 0.67 |
| POD 2 | 4 (2, 6) | 3 (2, 5) | 0.53 |
| POD 3 | 3 (2, 4) | 3 (1, 5) | 0.97 |
| POD 4 | 2 (1, 3) | 2 (2, 3) | 0.53 |
NO of LN dissected in thorax – total number of lymph nodes harvested during the thoracic stage, Low TV – number of patients adopting tidal volume less than 6 ml/kg predicted body weight during thoracic stage, NRS – Numeric Rating Scale.
Postoperative complications
| Complication | LLDP ( | PP ( | Value of |
|---|---|---|---|
| Minor: | 18 (47.4%) | 16 (76.2%) | |
| Hoarseness | 9 (23.7%) | 11 (52.4%) | 0.03 |
| Arrhythmia | 2 (5.3%) | 2 (9.5%) | 0.61 |
| Fever | 1 (2.6%) | 2 (9.5%) | 1.00 |
| Oozing of wound | 2 (5.3%) | 0 | 0.53 |
| Wound infection | 4 (10.5%) | 1 (4.8%) | 0.65 |
| Major: | 24 (63.2%) | 4 (19.0%) | |
| Vocal cord palsy | 1 (2.6%) | 1 (4.8%) | 1.00 |
| Pneumonia | 8 (21.1%) | 0 | 0.04 |
| Pleural effusion | 1 (2.6%) | 1 (4.8%) | 1.00 |
| Leakage | 9 (23.7%) | 2 (9.5%) | 0.30 |
| Atelectasis | 3 (7.9%) | 0 | 0.55 |
| Tracheal laceration | 1 (2.6%) | 0 | 1.00 |
| TE fistula | 1 (2.6%) | 0 | 1.00 |